The World Health Organisation will be sending a team of experts to China next week to investigate the origins of the coronavirus, while a vaccine has also been approved for use by the Chinese military.
On Monday, the green light was given to the Chinese military to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics, one of eight Chinese vaccine candidates approved for human trials. The vaccine, Ad5-nCoV, was approved by China’s Central Military Commission to be used for one year from June 25, according to a statement reported on by New York Times. Although, it has not been approved for anything outside of its military applications.
“The Ad5-nCoV is currently limited to military use only and its use cannot be expanded to a broader vaccination range without the approval of the Logistics Support Department,” CanSino said.
The first two phases of the CanSino trials have proved promising in its ability to prevent diseases caused by the coronavirus, but its chances of being commercially successful are still being questioned. CanSino’s vaccine is one of dozens that have gone to human trials from more than 100 that are being developed around the world.
Meanwhile, the World Health Organisation will now be conducting an investigation in China in order to study the origins of the coronavirus and to be better equipped for handling the ongoing outbreak.
“We can fight the virus better when we know everything about the virus, including how it started,” WHO head, Dr. Tedros Adhanom Ghebreyesus, said on Monday.
The United States, the biggest critic of the WHO, have threatened to leave the agency over its inaction with regards to the origins of the virus. President Donald Trump and his Secretary of State, Mike Pompeo, have accused China of developing COVID-19 in a laboratory, but there is no evidence to support the claim.